FLT3 and acute myeloid leukemia: It was observed that administration of low-dose CS055 potentiates the cytotoxicity of ABT-199 in vitro in various human AML cell lines and ex vivo in primary AML samples, as well as anti-leukemia efficacy in vivo in a PDX mouse model of AML carrying FLT3-ITD.